Heidi Henson's most recent trade in PepGen Inc was a trade of 16,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PepGen Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2025 | 15,789 | 55,269 (0%) | 0% | 0 | Common Stock | |
| PepGen Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 13,000 | 13,000 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 19,480 | 39,480 (0%) | 0% | 0 | Common Stock | |
| PepGen Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) | |
| Lisata Therapeutics Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2023 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
| PepGen Inc | Heidi Henson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 11,667 | 11,667 | - | - | Stock Option (Right to Buy) |